2

Risk : benefit assessment of old medicines

Year:
2004
Language:
english
File:
PDF, 144 KB
english, 2004
3

Homoeopathy: not a matter for drug-regulatory authorities

Year:
2009
Language:
english
File:
PDF, 89 KB
english, 2009
4

Discontinuation of Vioxx

Year:
2005
Language:
english
File:
PDF, 34 KB
english, 2005
5

A Critique to the European Regulatory System

Year:
2004
Language:
english
File:
PDF, 71 KB
english, 2004
8

Antiplatelet drugs and thrombosis prevention: Ticlopidine in perspective

Year:
1984
Language:
english
File:
PDF, 308 KB
english, 1984
9

Limits of add-on trials: antirheumatic drugs

Year:
2009
Language:
english
File:
PDF, 149 KB
english, 2009
12

Health care: Make pharma justify the price of drugs

Year:
2015
Language:
english
File:
PDF, 61 KB
english, 2015
14

Funding is not enough

Year:
2018
Language:
english
File:
PDF, 129 KB
english, 2018
18

Light and shade in proposed revision of EU drug-regulatory legislation

Year:
2003
Language:
english
File:
PDF, 55 KB
english, 2003
20

Toward new legislation on drugs in Europe

Year:
2002
Language:
english
File:
PDF, 86 KB
english, 2002
22

Adjusting Europe's drug regulation to public health needs

Year:
2001
Language:
english
File:
PDF, 68 KB
english, 2001
23

Health inequalities in Italy

Year:
1997
Language:
english
File:
PDF, 61 KB
english, 1997
25

Conditional approval of medicines by the EMA

Year:
2017
Language:
english
File:
PDF, 820 KB
english, 2017
26

Antioxidant strategy for cardiovascular disease

Year:
2001
Language:
english
File:
PDF, 43 KB
english, 2001
27

Europe's opportunity to open up drug regulation

Year:
2010
Language:
english
File:
PDF, 2.37 MB
english, 2010
28

Non-inferiority trials are unethical because they disregard patients' interests

Year:
2007
Language:
english
File:
PDF, 59 KB
english, 2007
29

The ethics of non-inferiority trials – Authors' reply

Year:
2008
Language:
english
File:
PDF, 52 KB
english, 2008
33

Orphan drug development is not taking off

Year:
2009
Language:
english
File:
PDF, 605 KB
english, 2009
34

Orphan drug development is progressing too slowly

Year:
2006
Language:
english
File:
PDF, 93 KB
english, 2006
35

Ethics in clinical research

Year:
2009
Language:
english
File:
PDF, 119 KB
english, 2009
37

A matter of public interest

Year:
2010
Language:
english
File:
PDF, 308 KB
english, 2010
39

Rosiglitazone and the need for a new drug safety agency

Year:
2010
Language:
english
File:
PDF, 622 KB
english, 2010
49

Do we learn the right things from clinical trials?

Year:
2008
Language:
english
File:
PDF, 195 KB
english, 2008